Are beta defensin 1 and beta defensin 2 key innate immune effector peptides against urinary tract infection in women?
Introduction & Hypothesis Recurrent urinary tract infection (rUTI) is a debilitating problem affecting 5% of women. Current treatment using intermittent or long-term antibiotics gives limited symptomatic benefit and encourages bacterial resistance. The aetiology of rUTI is unclear but may involv...
| Main Author: | |
|---|---|
| Published: |
University of Newcastle upon Tyne
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.618184 |